Questions About Cancer? 1-800-4-CANCER

Childhood Ependymoma Treatment (PDQ®)

Health Professional Version
Last Modified: 05/19/2014

Changes to This Summary (05/19/2014)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Childhood Ependymoma

Revised text to state that if feasible, cerebrospinal fluid cytological evaluation should be conducted.

Added Modena et al. as reference 17.

Treatment Option Overview for Childhood Ependymoma

Revised Table 1 to include observation as a standard treatment option for newly diagnosed childhood subependymoma.

Treatment of Newly Diagnosed Childhood Subependymoma

Added text to state that some subependymomas are considered incidental findings and observed without intervention.

Treatment of Newly Diagnosed Childhood Ependymoma or Anaplastic Ependymoma

Added Cage et al. as reference 6 and level of evidence 3iDii.

Added text to state that there are no contemporary studies published to support the approach of using radiation therapy to treat central nervous system disseminated disease.

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.